PER 4.94% 8.5¢ percheron therapeutics limited

DGWA and the German Australian Business Council (**C) are...

  1. 30 Posts.
    lightbulb Created with Sketch. 18
    DGWA and the German Australian Business Council (**C) are delighted to host the following virtual event. CEO Roundtable: Biotech Breakthroughs across Australia and Germany Tuesday, 1 March 2022 8:00am – 9:00 CET Online


    The global spotlight on the biotech industry over the pandemic has highlighted the importance and impact of the industry while accelerating innovation and investment across countries and companies. Join this discussion with leading CEOs from Australia and Germany as they navigate the biotech landscape from clinical trials to engaging stakeholders on their paths to commercial success.

    The speakers are:James Graham – CEO, Recce Pharmaceuticals, Mark Diamond – Managing Director & CEO, Antisense Therapeutics, Dr. Mohit Chhaya – Co-Founder & CEO, BellaSenoMarc Voigt – CEO & Executive Director, Immutep The session will be moderated byr. Julia Schueler - Chair, Founder & Owner Bio.AspekteDr. Lucia Santoso – Incoming Board Member, German Australian Business Council

    Registrations:

    https://us02web.zoom.us/meeting/register/tZUucu2uqzgrGNxWPzMcnXaQ_kBF-WHacj58


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.